HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
Welcome! | Welcome! | ||
* For assignments, please see the "Author" column below (3rd column from left). If no name is present, volunteer to create content! | *For assignments, please see the "Author" column below (3rd column from left). If no name is present, volunteer to create content! | ||
* To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest. | *To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest. | ||
{| class="wikitable" style="margin:auto" | {| class="wikitable" style="margin:auto" | ||
| Line 898: | Line 898: | ||
| | | | ||
| | | | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
|- | |- | ||
|Blastic plasmacytoid dendritic cell neoplasm | |Blastic plasmacytoid dendritic cell neoplasm | ||
| Line 914: | Line 914: | ||
| | | | ||
| | | | ||
| | |Blastic Plasmacytoid Dendritic Cell Neoplasm | ||
|Hao Liu, MD and Daynna J. Wolff, PhD | |Hao Liu, MD and Daynna J. Wolff, PhD | ||
|Complete | |||
| | | | ||
| | |Previously within myeloid section under JH/MS editors | ||
|- | |- | ||
|Langerhans cell histiocytosis | |Langerhans cell histiocytosis | ||
| Line 930: | Line 930: | ||
| | | | ||
| | | | ||
| | |Langerhans Cell Histiocytosis | ||
|Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland | |Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland | ||
| | |Complete | ||
| | |5/19/2022<br /> | ||
| | |Date completed by author: 04/28/2022 | ||
|- | |- | ||
|Langerhans cell sarcoma | |Langerhans cell sarcoma | ||
| Line 946: | Line 946: | ||
| | | | ||
| | | | ||
| | |Langerhans Cell Sarcoma | ||
|Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland | |Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland | ||
| | |Complete | ||
| | |5/19/2022<br /> | ||
| | |Date completed by author: 04/28/2022 | ||
|- | |- | ||
|Indeterminate dendritic cell tumour | |Indeterminate dendritic cell tumour | ||
| Line 962: | Line 962: | ||
| | | | ||
| | | | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
|- | |- | ||
|Interdigitating dendritic cell sarcoma | |Interdigitating dendritic cell sarcoma | ||
| Line 978: | Line 978: | ||
| | | | ||
| | | | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
|- | |- | ||
|Juvenile xanthogranuloma | |Juvenile xanthogranuloma | ||
| Line 994: | Line 994: | ||
| | | | ||
| | | | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
|- | |- | ||
|Erdheim-Chester disease | |Erdheim-Chester disease | ||
| Line 1,010: | Line 1,010: | ||
| | | | ||
| | | | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
|- | |- | ||
|Rosai-Dorfman Disease | |Rosai-Dorfman Disease | ||
| Line 1,026: | Line 1,026: | ||
| | | | ||
| | | | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
|- | |- | ||
|ALK-positive histiocytosis | |ALK-positive histiocytosis | ||
| Line 1,042: | Line 1,042: | ||
| | | | ||
| | | | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
|- | |- | ||
|Histiocytic sarcoma | |Histiocytic sarcoma | ||
| Line 1,058: | Line 1,058: | ||
| | | | ||
| | | | ||
| | |Histiocytic Sarcoma | ||
|Marie-France Gagnon, MD, Mayo Clinic, Xinjie Xu, PhD FACMG, Mayo Clinic | |Marie-France Gagnon, MD, Mayo Clinic, Xinjie Xu, PhD FACMG, Mayo Clinic | ||
| | | | ||